4 years, 7 months ago

Potential way found to tackle autism

CHICAGO - A novel precision medicine approach, enhanced by artificial intelligence, has laid the groundwork for what could be the first biomedical screening and intervention tool for a subtype of autism, according to a new study. The subtype of the disorder studied by researchers from Northwestern University, Ben-Gurion University of the Negev, Harvard University and the Massachusetts Institute of Technology is known as dyslipidemia-associated autism, which represents 6.55 percent of all diagnosed autism spectrum disorders in the United States. The study's co-first author Yuan Luo, associate professor of preventive medicine at NU's Feinberg School of Medicine, says: "This discovery was like finding a needle in a haystack, as there are thousands of variants in hundreds of genes thought to underlie autism, each of which is mutated in less than 1 percent of families with the disorder. "The map and magnifier approach showcases a generalizable way of using multiple data modalities for subtyping autism," says Luo. "Today, autism is diagnosed based only on symptoms, and the reality is when a physician identifies it, it's often when early and critical brain developmental windows have passed without appropriate intervention," says Luo.

China Daily
Autism Luo
Autism and cholesterol might be linked, research finds
4 years, 7 months ago

Autism and cholesterol might be linked, research finds

Hindustan Times
Children

Discover Related